FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013111520> ?p ?o ?g. }

• W2013111520 abstract "Abstract Background Studies have shown that ischemia-reperfusion (I/R) produces free radicals leading to lipid peroxidation and damage to skeletal muscle. The purposes of this study were 1) to assess the histological findings of gastrocnemius muscle (GC) and tibialis anterior muscle (TA) in I/R injury model mice, 2) to histologically analyze whether a single pretreatment of edaravone inhibits I/R injury to skeletal muscle in murine models and 3) to evaluate the effect of oxidative stress on these muscles. Methods C57BL6 mice were divided in two groups, with one group receiving 3 mg/kg intraperitoneal injections of edaravone (I/R + Ed group) and the other group receiving an identical amount of saline (I/R group) 30 minutes before ischemia. Edaravone (3-methy-1-pheny1-2-pyrazolin-5-one) is a potent and novel synthetic scavenger of free radicals. This drug inhibits both nonenzymatic lipid peroxidation and the lipoxygenase pathway, in addition to having potent antioxidant effects against ischemia reperfusion. The duration of the ischemia was 1.5 hours, with reperfusion at either 24 or 72 hours (3 days). Specimens of gastrocnemius (GC) and anterior tibialis (TA) were removed for histological evaluation and biochemical analysis. Results This model of I/R injury was highly reproducible in histologic muscle damage. In the histologic damage score, the mean muscle fibers and inflammatory cell infiltration in the I/R + Ed group were significantly less than the corresponding values of observed in the I/R group. Thus, pretreatment with edaravone was observed to have a protective effect on muscle damage after a period of I/R in mice. In addition, the mean muscle injury score in the I/R + Ed group was also significantly less than the I/R group. In the I/R + Ed group, the mean malondialdehyde (MDA) level was lower than in the I/R group and western-blotting revealed that edaravone pretreatment decreased the level of inducible nitric oxide synthase (iNOS) expression. Conclusions Edaravone was found to have a protective effect against I/R injury by directly inhibiting lipid peroxidation of the myocyte by free radicals in skeletal muscles and may also reduce the secondary edema and inflammatory infiltration incidence of oxidative stress on tissue." @default.
• W2013111520 created "2016-06-24" @default.
• W2013111520 creator A5004119695 @default.
• W2013111520 creator A5023127801 @default.
• W2013111520 creator A5031035276 @default.
• W2013111520 creator A5031388685 @default.
• W2013111520 creator A5037745620 @default.
• W2013111520 creator A5038213232 @default.
• W2013111520 creator A5042557807 @default.
• W2013111520 creator A5057457140 @default.
• W2013111520 creator A5058604770 @default.
• W2013111520 date "2013-03-27" @default.
• W2013111520 modified "2023-09-25" @default.
• W2013111520 title "Protective effect of edaravone for tourniquet-induced ischemia-reperfusion injury on skeletal muscle in murine hindlimb" @default.
• W2013111520 cites W1519472981 @default.
• W2013111520 cites W1571779957 @default.
• W2013111520 cites W1909061788 @default.
• W2013111520 cites W1965693998 @default.
• W2013111520 cites W1967896374 @default.
• W2013111520 cites W1971317435 @default.
• W2013111520 cites W1980901540 @default.
• W2013111520 cites W1981881424 @default.
• W2013111520 cites W1983688860 @default.
• W2013111520 cites W1987312379 @default.
• W2013111520 cites W1994984554 @default.
• W2013111520 cites W1996161774 @default.
• W2013111520 cites W2024729321 @default.
• W2013111520 cites W2030894742 @default.
• W2013111520 cites W2031511345 @default.
• W2013111520 cites W2034353359 @default.
• W2013111520 cites W2038254164 @default.
• W2013111520 cites W2038826532 @default.
• W2013111520 cites W2051752915 @default.
• W2013111520 cites W2052080273 @default.
• W2013111520 cites W2058084692 @default.
• W2013111520 cites W2067928777 @default.
• W2013111520 cites W2075023171 @default.
• W2013111520 cites W2081620510 @default.
• W2013111520 cites W2086836124 @default.
• W2013111520 cites W2097744068 @default.
• W2013111520 cites W2101396622 @default.
• W2013111520 cites W2102723961 @default.
• W2013111520 cites W2105651021 @default.
• W2013111520 cites W2115861406 @default.
• W2013111520 cites W2116527742 @default.
• W2013111520 cites W2124662833 @default.
• W2013111520 cites W2127482441 @default.
• W2013111520 cites W2144184739 @default.
• W2013111520 cites W2157775555 @default.
• W2013111520 cites W2160308360 @default.
• W2013111520 cites W2163126481 @default.
• W2013111520 cites W2170907147 @default.
• W2013111520 cites W2188308812 @default.
• W2013111520 cites W2337937663 @default.
• W2013111520 cites W2418455196 @default.
• W2013111520 cites W4254576022 @default.
• W2013111520 doi "https://doi.org/10.1186/1471-2474-14-113" @default.
• W2013111520 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3614524" @default.
• W2013111520 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23530927" @default.
• W2013111520 hasPublicationYear "2013" @default.
• W2013111520 type Work @default.
• W2013111520 sameAs 2013111520 @default.
• W2013111520 citedByCount "30" @default.
• W2013111520 countsByYear W20131115202013 @default.
• W2013111520 countsByYear W20131115202014 @default.
• W2013111520 countsByYear W20131115202015 @default.
• W2013111520 countsByYear W20131115202016 @default.
• W2013111520 countsByYear W20131115202017 @default.
• W2013111520 countsByYear W20131115202018 @default.
• W2013111520 countsByYear W20131115202019 @default.
• W2013111520 countsByYear W20131115202020 @default.
• W2013111520 countsByYear W20131115202021 @default.
• W2013111520 countsByYear W20131115202022 @default.
• W2013111520 countsByYear W20131115202023 @default.
• W2013111520 crossrefType "journal-article" @default.
• W2013111520 hasAuthorship W2013111520A5004119695 @default.
• W2013111520 hasAuthorship W2013111520A5023127801 @default.
• W2013111520 hasAuthorship W2013111520A5031035276 @default.
• W2013111520 hasAuthorship W2013111520A5031388685 @default.
• W2013111520 hasAuthorship W2013111520A5037745620 @default.
• W2013111520 hasAuthorship W2013111520A5038213232 @default.
• W2013111520 hasAuthorship W2013111520A5042557807 @default.
• W2013111520 hasAuthorship W2013111520A5057457140 @default.
• W2013111520 hasAuthorship W2013111520A5058604770 @default.
• W2013111520 hasBestOaLocation W20131115201 @default.
• W2013111520 hasConcept C126322002 @default.
• W2013111520 hasConcept C134018914 @default.
• W2013111520 hasConcept C2775872116 @default.
• W2013111520 hasConcept C2776151105 @default.
• W2013111520 hasConcept C2776379899 @default.
• W2013111520 hasConcept C2779400597 @default.
• W2013111520 hasConcept C2779554857 @default.
• W2013111520 hasConcept C2779959927 @default.
• W2013111520 hasConcept C2780114680 @default.
• W2013111520 hasConcept C2780829032 @default.
• W2013111520 hasConcept C2992339995 @default.
• W2013111520 hasConcept C42219234 @default.
• W2013111520 hasConcept C51738704 @default.
• W2013111520 hasConcept C541997718 @default.
• W2013111520 hasConcept C71924100 @default.

• next